Disruption of the BCR signaling pathway in CLL is characterized by active phosphorylation of specific kinases, including BTK, SYK, and PI3K, and variable response to IgM stimulation [55]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.